2016-05-02 22:38:21 UTC

Freston Conference Session 2 Overview: Stems Cells and the GI Tract

May 3, 2016

The August conference will delve deeper into the topic of intestinal metaplasia in the esophagus and stomach.

In a new series of articles, we are highlighting various 2016 Freston Conference sessions to provide you with insight on what to expect when you attend. In the first installment, we previewed session one of the conference. This week we've provided an overview of session two.

The conference, which takes place Aug. 19–21, 2016, in Chicago, IL, will delve deeper into the pathogenesis, biology and translational features of intestinal metaplasia in the esophagus and stomach.

See highlights from session two below: 

Stem Cells and their Lineage in Normal Development of the Esophagus, Stomach and Intestine
Session two takes a closer look at the role stem cells play in the structure and development of the GI tract, further detailing the impact of these unique cells on human health and disease.

  • How esophageal basal cells can provide researchers with advanced insight into homeostasis and regenerative medicine.
  • What lessons can be applied to intestinal metaplasia from recent research in pancreatic acinar metaplasia?
  • How metaplasia is "fueled" by the reprogramming of mature cells.

The series will continue with details on session threeTo register and view the program in its entirety, visit the conference Web page.

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.